Human Papillomavirus in Young People Epidemiological Research 4
- Conditions
- HPV InfectionCancerHPV 16 InfectionHuman Papillomavirus InfectionHPVAnal CancerMen
- Registration Number
- NCT05587738
- Lead Sponsor
- Monash University
- Brief Summary
Anal cancer is overrepresented among gay, bisexual and other men who have sex with men (MSM), particularly those living with HIV. Australia was the first country to introduce a publicly funded national HPV vaccination program in 2007. This program was expanded to include schoolboys aged 12-13 years in 2013; with a 2-year catch-up for boys aged up to 15 years.
The goal of the HYPER4 study is to determine the prevalence of anal, genital and oral HPV among 500 young gay and bisexual men aged 21-25 years who were eligible for the school-based gender-neutral quadrivalent vaccination program.
Participants will be required to complete a questionnaire and provide samples for HPV testing. No follow-up visits will be required.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- Male
- Target Recruitment
- 500
- Men aged 21 to 25 years old in 2023-2024
- Same-sex attracted
- Residing in Australia since 2013
- Unable to complete all study requirements in English
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Prevalence of type-specific HPV types Baseline The oral, penile and anal prevalence of type-specific HPV types
Prevalence of quadrivalent vaccine HPV types Baseline The oral, penile and anal prevalence of quadrivalent vaccine types (6, 11, 16 and 18)
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Melbourne Sexual Health Centre
🇦🇺Melbourne, Victoria, Australia